Celltrion USA Launches Yuflyma® (adalimumab-aaty), a Humira® (adalimumab) biosimilar, in the United States

Celltrion USA announced the launch of Yuflyma®, a high-concentration and citrate-free formulation of Humira® biosimilar, providing an alternative option for patients.